Additionally, FXR activation enhances insulin sensitivity through various mechanisms [258], such as reducing hepatic steatosis [259], enhancing lipid metabolism [248,260], and exerting anti-inflammatory effects [261]. The gene discussed is NR1H4; the disease is fatty liver disease.